Correlation Engine 2.0
Clear Search sequence regions

  • cancer (1)
  • COX (1)
  • COX7A2 (11)
  • glioma (9)
  • good prognosis (2)
  • kaplan meier (1)
  • paraffin (1)
  • patients (5)
  • prognostic (5)
  • research (1)
  • Sizes of these terms reflect their relevance to your search.

    Cytochrome c oxidase subunit 7A2 (COX7A2) is a nuclear-encoded polypeptide involved in assembly and regulation of cytochrome c oxidase (COX). Changes in the respiratory chain as big complex are known to be associated with cancer, but little research has been performed to discover COX7A2 as a prognostic marker in glioma. In the present study, we investigated COX7A2 expression and its prognostic significance in glioma. Glioma surgical tissue samples were taken from 126 patients who had been followed up from 4 to 51 months. Immunohistochemistry were used to test COX7A2 expression in the 126 tumor samples. Eighty-six of 126 (68.3%) paraffin-embedded glioma biopsies showed high expression of COX7A2. Statistical analysis displayed that there was significant difference of COX7A2 expression level in patients categorized according to WHO classification. Kaplan-Meier survival analysis revealed that patients with higher COX7A2 expression had longer overall survival time and better prognosis. R2: microarray analysis based on Tumor Glioma French 284 database, Tumor Glioblastoma TCGA 540 database, and Tumor Glioma Kawaguchi 50 database testified that high expression of COX7A2 is associated with a good prognosis in patients with glioma. Multivariate analysis showed that COX7A2 high expression was an independent prognostic indicator for survival. Our results suggest that COX7A2 could be served as a valuable prognostic marker of glioma.


    Shengze Deng, Yaomin Li, Guozhong Yi, Bingxi Lei, Manlan Guo, Wei Xiang, Ziyang Chen, Yawei Liu, Songtao Qi. Overexpression of COX7A2 is associated with a good prognosis in patients with glioma. Journal of neuro-oncology. 2017 Oct 27

    PMID: 29079956

    View Full Text